What does good look like in a medical aesthetics asset? We can tell you.
What does good look like in a medical aesthetics asset? We can tell you.
What does good look like in a medical aesthetics asset? We can tell you.
Operator-level diligence that reveals true asset quality: compliance, physician alignment, clinical infrastructure, and long-term durability.
Operator-level diligence that reveals true asset quality: compliance, physician alignment, clinical infrastructure, and long-term durability.
/
The problem
Financial metrics alone do not predict asset durability.
Financial metrics alone do not predict asset durability.
Financial metrics alone do not predict asset durability.
In a fragmented sector, the variance between high-quality and at-risk assets is enormous. But the signals are clinical and operational, not financial. A practice can show strong revenue and margins while carrying significant compliance exposure, physician alignment risk, or injector concentration that creates fragility.
One of the most common patterns we see: one or two A-player injectors generating a disproportionate share of revenue. That concentration dilutes long-term viability and transferability. The asset looks strong on paper, but the value walks out the door if those providers leave.
Calyxe brings the wherewithal to identify that risk and, critically, to replicate the qualities of top performers across the clinical team so the practice becomes sustainable independent of any single provider.
In a fragmented sector, the variance between high-quality and at-risk assets is enormous. But the signals are clinical and operational, not financial. A practice can show strong revenue and margins while carrying significant compliance exposure, physician alignment risk, or injector concentration that creates fragility.
One of the most common patterns we see: one or two A-player injectors generating a disproportionate share of revenue. That concentration dilutes long-term viability and transferability. The asset looks strong on paper, but the value walks out the door if those providers leave.
Calyxe brings the wherewithal to identify that risk and, critically, to replicate the qualities of top performers across the clinical team so the practice becomes sustainable independent of any single provider.
What the spreedsheet misses
What the spreedsheet misses
Revenue concentration in 1-2 key providers. Medical director agreements that will not survive regulatory scrutiny. CPOM exposure that requires entity restructuring post-close. Delegation models that limit which services can scale. Advertising and marketing compliance gaps that create liability.
Revenue concentration in 1-2 key providers. Medical director agreements that will not survive regulatory scrutiny. CPOM exposure that requires entity restructuring post-close. Delegation models that limit which services can scale. Advertising and marketing compliance gaps that create liability.
What Calyxe evaluates
What Calyxe evaluates
The clinical, compliance, and operational variables that determine whether an asset will hold up under institutional ownership or begin deteriorating after close. We see what financial models cannot capture.
The clinical, compliance, and operational variables that determine whether an asset will hold up under institutional ownership or begin deteriorating after close. We see what financial models cannot capture.
/
The framework
Four dimensions of asset quality.
Four dimensions of asset quality.
Four dimensions of asset quality.
Each dimension evaluates a structural layer that financial diligence typically does not reach. Together, they give institutional buyers a complete picture of what they are acquiring.
Each dimension evaluates a structural layer that financial diligence typically does not reach. Together, they give institutional buyers a complete picture of what they are acquiring.
01
Compliance posture
Compliance posture
Compliance posture
CPOM exposure assessment, state licensing verification, advertising and entity compliance review. Identifies regulatory risk that could require restructuring or create liability post-acquisition.
CPOM exposure assessment, state licensing verification, advertising and entity compliance review. Identifies regulatory risk that could require restructuring or create liability post-acquisition.
02
Physician alignment
Physician alignment
Physician alignment
Medical director agreement review, oversight structure evaluation, and delegation risk analysis. Assesses whether the physician relationship will hold under institutional ownership and regulatory scrutiny.
Medical director agreement review, oversight structure evaluation, and delegation risk analysis. Assesses whether the physician relationship will hold under institutional ownership and regulatory scrutiny.
03
Clinical infrastructure
Clinical infrastructure
Clinical infrastructure
Injector quality assessment, retention pattern analysis, training standards review, and key-person concentration risk. Evaluates whether revenue is sustainable or dependent on providers who could leave.
Injector quality assessment, retention pattern analysis, training standards review, and key-person concentration risk. Evaluates whether revenue is sustainable or dependent on providers who could leave.
04
Operational scalability
Operational scalability
Operational scalability
Systems, processes, and management team readiness for institutional ownership. Determines whether the practice can be replicated, standardized, and integrated into a portfolio without rebuilding from scratch.
Systems, processes, and management team readiness for institutional ownership. Determines whether the practice can be replicated, standardized, and integrated into a portfolio without rebuilding from scratch.
/
The engagement
How the assessment works.
Structured to integrate with your deal timeline. Scope, deliverables, and reporting calibrated to what investment committees and operating partners need to make decisions.
Scope and intake
Define the target asset, deal timeline, and specific diligence questions. Calyxe aligns assessment scope to your investment thesis and committee requirements.
Site and document review
Clinical operations assessment, compliance document review, provider interviews, and physician alignment evaluation. Hands-on, operator-level diligence across all four dimensions.
Findings and risk report
Structured deliverable covering compliance posture, physician alignment, clinical infrastructure depth, and operational scalability. Includes risk ratings and remediation pathways.
Deal-team integration
Presentation to investment committee or operating partners. Available for follow-up diligence questions, negotiation support, and post-close integration planning.
Request an assessment briefing.
Request an assessment briefing.
Request an assessment briefing.
Trusted Partner
Collaborative Approach
Lasting Value